Neuropsikofarmakologia Ikerketa Taldea

• García-Bueno B, Gassó P, MacDowell KS, Callado LF, Mas S, Bernardo M, Lafuente A, Meana JJ, Leza JC.  Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia Journal of Psychiatry & Neuroscience,  2016;  41,  E46 - 55
• Rivero G, Martín-Guerrero I, de Prado E, Gabilondo AM, Callado LF, García-Sevilla JA, García-Orad Á, Meana JJ.  Alpha2C-adrenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependence World Journal of Biological Psychiatry,  2016;  17,  308 - 315
• Pinacho R, Villalmanzo N, Meana JJ, Ferrer I, Berengueras A, Haro JM, Villén J, Ramos B.  Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia Schizophrenia Research,  2016;  177,  88 - 97
• Horrillo I, Ortega JE, Diez-Alarcia R, Urigüen L, Meana JJ.  Effect of subchronic corticosterone administration on α(2)-adrenoceptor functionality in rat brain: an in vivo and in vitro study Psychopharmacology,  2016;  233,  3861 - 3867
• McMullan M, García-Bea A, Miranda-Azpiazu P, Callado LF, Rozas I.  Substituted conformationally restricted guanidine derivatives: Probing the α(2)-adrenoceptors' binding pocket European Journal of Medicinal Chemistry,  2016;  123,  48 - 57
• Andradas C, Blasco-Benito S, Castillo-Lluva S, Dillenburg-Pilla P, Diez-Alarcia R, Juanes-García A, García-Taboada E, Hernando-Llorente R, Soriano J, Hamann S, Wenners A, Alkatout I, Klapper W, Rocken C, Bauer M, Arnold N, Quintanilla M, Megías D, Vicente-Manzanares M, Urigüen L, Gutkind JS, Guzmán M, Pérez-Gómez E, Sánchez C.  Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer Oncotarget,  2016;  7,  47565 - 47575
• Diez-Alarcia R, Ibarra-Lecue I, Lopez-Cardona ÁP, Meana J, Gutierrez-Adán A, Callado LF, Agirregoitia E, Urigüen L.  Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex Frontiers in Pharmacology,  2016;  7, 415
• Muguruza C, Meana JJ, Callado LF.  Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs Frontiers in Pharmacology,  2016;  7,130
• Moreno JL., Miranda-Azpiazu, P, Garcia-Bea A, Younkin J, Cui M, Kozlenkov A, Ben-Ezra A, Voloudakis G, Fakira AK, Baki L, Ge Y, Georgakopoulos A, Moron JA, Milligan G, Lopez-Gimenez JF, Robakis NK, Logothetis DE, Meana JJ, Gonzalez-Maeso J.  Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia Science Signaling,  2016;  9 : ra5